LNAI
Lunai Bioworks Inc.
Key Financials
Gross Profit
$37494
0.0%
Operating Income
$-188966002
↓ 131.5%
Net Income
$-178007489
↓ 120.7%
Revenue
$0
NaN%
EPS (Diluted)
$-1.08
↓ 28.6%
Total Assets
$8.2M
↓ 95.0%
Shareholders' Equity
$-21349841.00
↓ 116.2%
Total Liabilities
$29.6M
↓ 5.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/17/2026 | View on SEC |
| 8-K | 6/16/2026 | View on SEC |
| 8-K | 5/20/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 8-K/A | 5/11/2026 | View on SEC |
| DEFR14A | 5/1/2026 | View on SEC |
| 8-K | 5/1/2026 | View on SEC |
| 8-K | 4/28/2026 | View on SEC |
| DEFA14A | 4/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LNAI |
| Company Name | Lunai Bioworks Inc. |
| CIK | 1527728 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 45 39179840 |